Your search returned 8 studies. (Get alerts for new studies):
- Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: Autoimmune Disease - Lymphatic Disease - Lymphoproliferative Disorder - Canale-Smith Syndrome
1 Location available
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Conditions: Leukemia - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Disease - Leukemia, Lymphocytic, Chronic - Lymphoproliferative Disorders
1 Location available
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Conditions: Hemophagocytic Lymphohistiocytosis - X-Linked Lymphoproliferative Disorders - Chediak-Higashi Syndrome - Griscelli Syndrome - Immunologic Diseases - Langerhans-Cell Histiocytosis - Hematologic Diseases
1 Location available
- Sirolimus for Autoimmune Disease of Blood Cells
Conditions: Autoimmune Pancytopenia - Autoimmune Lymphoproliferative Syndrome (ALPS) - Evans Syndrome - Idiopathic Thrombocytopenic Purpura - Anemia, Hemolytic, Autoimmune - Autoimmune Neutropenia - Lupus Erythematosus, Systemic - Inflammatory Bowel Disease - Rheumat
1 Location available
- Bortezomib Plus Rituximab for EBV+ PTLD
Conditions: Post-transplant Lymphoproliferative Disease - Solid Organ Transplant - Stem Cell Transplant (Bone Marrow Transplant) - Epstein Barr Virus Infections
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- HLA-Matched Allogeneic Cytotoxic T Lymphocytes (CTLs) for Treatment of Patients With Relapsed Epstein Barr Virus (EBV)-Associated Diseases
Conditions: Hodgkin Lymphoma - Non-Hodgkin Lymphoma - Lymphoproliferative Disorder - Nasopharyngeal Carcinoma - Leiomyosarcoma
2 Locations available
|